pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Dana-Farber and Beth Israel Lahey Health break ground on $1.68 billion cancer hospital in Boston

Oct 20, 2026·read at STAT ↗DealPositive

Officials from Dana-Farber Cancer Institute and Beth Israel Lahey Health announced the start of construction on a new dedicated cancer hospital in Boston's Longwood area. The project is budgeted at $1.68 billion and will be the only facility of its kind in New England.

The new building is intended to consolidate oncology services under one roof, giving the partners greater control over patient care and research. Dr. Benjamin Ebert, chief executive of Dana-Farber, said seeing the cranes and envisioning the completed campus is motivating for the team.

The development also signals a shift in the regional cancer care landscape, as Dana-Farber moves away from its historic affiliation with Brigham and Women’s Hospital. At the same time, Mass General Brigham, the parent of Brigham, is advancing its own cancer institute and renovating facilities to stay competitive.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital”

read at STAT ↗
424 words · retrieved 27m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Dana-Farber Cancer Institute Inc3
topics
Oncology16

related stories

  • Sep 17Rare EGFR mutation increases lung cancer risk 62 times in never smokersFierce Biotech
  • Sep 4STAT+: Top Boston hospitals clash over Medicare Advantage network after splitSTAT
  • Aug 13STAT+: As young people increasingly get cancer, new fertility options are changing their futuresSTAT
  • May 31#ASCO26: Personalized cancer vaccines may help brain cancer patients live longerEndpoints
  • May 29Bristol Myers unveils data for one of its next-gen blood cancer drugsBioPharma Dive